Edge AI Demand And Rising R&D Will Shape A Complicated Long Term Outlook

Catalysts

About Ambiq Micro

Ambiq Micro designs and sells ultra low power semiconductors and software platforms that enable AI processing at the edge for wearables, industrial devices and other connected products.

What are the underlying business or industry changes driving this perspective?

• Although demand for edge AI in wearables, health devices and industrial monitoring is broadening, Ambiq is increasing R&D and SG&A to support Apollo and Atomiq product families. This could keep net losses elevated and delay improvement in earnings even if revenue builds as expected.
• While the company has repositioned away from lower margin Mainland China sales and is seeing mid to low 40% gross margins, further product and customer diversification into new edge AI markets may require pricing concessions and heavier go to market spend. This could limit future gross margin expansion and operating margin improvement.
• Although Apollo5 and newer Apollo330 Plus and Apollo510 Lite products are gaining interest as proxies for edge AI adoption, customer ramps in areas like AR glasses and industrial predictive maintenance depend on successful volume launches. Any slower than anticipated production ramps would affect revenue growth and delay scale benefits in gross profit.
• Despite growing customer use cases for local speech recognition, health monitoring and predictive sensing, many of these deployments are still in early stages. This means unit volumes and associated ASP uplift from higher value edge AI features may build more gradually than expected, tempering revenue and earnings progress.
• While the Atomiq platform and SPOT IP licensing effort target higher performance AI and a potential new royalty stream, Atomiq is still in active development and the licensing model is framed over a 3 to 5 year commercialization horizon. Any slips in timelines or customer adoption would defer anticipated contributions to revenue mix and net margin.

Assumptions

This narrative explores a more pessimistic perspective on Ambiq Micro compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts. How have these above catalysts been quantified?

• The bearish analysts are assuming Ambiq Micro's revenue will grow by 31.8% annually over the next 3 years.
• The bearish analysts are not forecasting that Ambiq Micro will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Ambiq Micro's profit margin will increase from -49.9% to the average US Semiconductor industry of 14.7% in 3 years.
• If Ambiq Micro's profit margin were to converge on the industry average, you could expect earnings to reach $24.3 million (and earnings per share of $1.08) by about January 2029, up from $-36.0 million today.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 39.8x on those 2029 earnings, up from -17.0x today. This future PE is lower than the current PE for the US Semiconductor industry at 42.0x.
• The bearish analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 10.52%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Edge AI in wearables, health care, smart buildings and industrial monitoring is described as one of the fastest growing segments in semiconductors, and Ambiq is seeing increased orders, design wins and Apollo5 production ramps. If this broader adoption continues it could support stronger revenue growth than you expect and put upward pressure on the share price through higher sales and gross profit.
• Apollo5, Apollo330 Plus, Apollo510 Lite and the upcoming Atomiq platform are already attracting interest from major high volume customers across use cases like AR glasses, predictive maintenance and intelligent audio. If these ramps scale successfully they could lift average selling prices and mix, which may support higher gross margins and accelerate earnings.
• The company reports non GAAP gross margin of 44.8% on net sales of US$18.2 million, a strong balance sheet with US$146.5 million in cash and no debt, and guidance that implies its strongest quarterly net sales of the year. Effective use of this cash to fund R&D and go to market efforts could support better than expected long term revenue, net margin and earnings outcomes.
• Management is actively investing IPO proceeds into expanding engineering headcount and commercial resources, while also planning to commercialize SPOT as a licensable platform in 3 to 5 years. If these efforts result in material IP licensing income and broader customer adoption, that could increase revenue diversity, improve net margins and support a higher valuation multiple than you anticipate.
• The pivot away from low margin Mainland China business towards higher value customers has coincided with higher average selling prices and stronger gross profit on slightly lower net sales. If this repositioned base continues to attract new design wins and ramps, it could support sustained gross margin expansion and improve the trajectory of net losses toward profitability faster than you expect.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for Ambiq Micro is $32.0, which represents up to two standard deviations below the consensus price target of $38.0. This valuation is based on what can be assumed as the expectations of Ambiq Micro's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $48.0, and the most bearish reporting a price target of just $32.0.
  
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $165.0 million, earnings will come to $24.3 million, and it would be trading on a PE ratio of 39.8x, assuming you use a discount rate of 10.5%.
  
• Given the current share price of $33.34, the analyst price target of $32.0 is 4.2% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.